Nuclear Medicine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024- Increasing prevalence of anxiety drives the nuclear medicine market.
Global Nuclear Medicine market is valued at USD 8.12 Million in 2018 and expected to reach USD 15.8 Million by 2025 with the CAGR of 10.1 %over the forecast period.
Nuclear medicine is involving the application of radioactive substances in the diagnosis and treatment of various diseases. Nuclear Medicine images can support the physician in diagnosing of many diseases and conditions such as analyze kidney and spleen function, image blood flow and function of the heart and scan the lungs for respiratory and blood-flow problems. Nuclear medicine uses radioactive materials helps to diagnose and treat a wide variety of diseases and disorders. It provides unique information about the human body and health. Nowadays nuclear medicine is expected to be the most sensitive approach to measure in vivo physiology, biochemistry and metabolism. The future development of nuclear medicine depends on an infrastructure of physics, mathematics and chemical biology.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=91587&RequestType=Sample
Global nuclear medicine market report is segmented on the basis of type, procedural volumes, application, end-user and regional & country level. Based upon type, nuclear medicine market is classified as diagnostic nuclear medicine, therapeutic nuclear medicine, research nuclear medicine and other. Based upon procedural volumes, nuclear medicine market is classified into diagnostic procedures, therapeutic procedures and other. Based upon application, nuclear medicine market is classified into oncology, cardiology, neurology, thyroid, lymphoma, endocrinology and other. Based upon end-user, nuclear medicine market is classified into diagnostic centers, hospitals, research centers and other.
The regions covered in this Global Nuclear Medicine market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Nuclear Medicine is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Nuclear Medicine Market Reports–
Global Nuclear Medicine Market Report covers prominent players are like Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Isotec, Ntp Radioisotopes (Pty), Ltd., Siemens Healthcare (Subsidiary Of Siemens AG), Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries, Ltd., Inc. and others.
News: June 27th, 2019 (Bracco Imaging Expanded Portfolio of Personalized Diagnostics with the Acquisition of Blue Earth Diagnostics) Bracco Imaging S.p.A., a global leader in diagnostic imaging announced that it had signed a definitive agreement to accumulate Blue Earth medicine, a molecular imaging company primarily based in Oxford, UK. Subject to customary closing conditions, completion of the transaction is expected in Q3 of this calendar year. Bracco Imaging will acquire all outstanding shares of privately-held Blue Earth Diagnostics for the equity value of $ 450 million, plus closing adjustment estimated at $25 million, from leading healthcare company syncona and blue Earth Medicine management team.
Increasing prevalence of anxiety and diagnosis of various disorders drives the nuclear medicine market.
Growing prevalence of anxiety and diagnosis of various disorders is driving the nuclear medicine market. Pharmaceutical agents play a major role in the prevention of atherosclerosis and its consequences such as heart attack, stroke, and heart failure. The prevalence of anxiety disorders across the world varies from 2.5 to 7 % by country. Globally, it is expected that around 284 million people experienced an anxiety disorder in 2017, making it the most prevalent mental health or neurodevelopmental disorder. The rising prevalence of cancer and cardiovascular diseases (CVD) are the key factor supporting nuclear medicine market growth. Cancer care providers should be trained to recognize CVD and provide any necessary interventions concurrently with cancer therapy. However, high cost, shortage of isotopes, and risk from traditional/alternative diagnostic procedures are hampering the growth of the market. Increasing production of radio pharmaceuticals from cyclotrons, efficient diagnosis and treatments, increasing therapeutic application areas and replacement of old/traditional equipment are some of the opportunities that are boosting the growth of the market.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=91587&RequestType=Methodology
North America is dominating the Nuclear Medicine Market
North America expected to grow large amount of diagnostic radioisotopes segment in Nuclear Medicine market. The Volume of PET/CT procedures performed, whereas cardiology and neurology account for about 4% each. Nuclear cardiology represents more than 50% of the nuclear medicine procedures done in the United States; on the other hand, it signifies only 14% of those done in Europe. In Asia-Pacific, the medical use of ionizing radiation remains a rapidly changing field, and medical radiation exposure has been on the rise, with 39% of the Asia-Pacific countries in healthcare level. The Asia-Pacific region is growing economically despite the economic decline away in the developed countries.
Key Benefits for Global Nuclear Medicine Market Reports –
Global market report covers in depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Global-Nuclear-Medicine-Market/Summary
Global Nuclear Medicine Market Segmentation –
By Type: –
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Research Nuclear Medicine
Other
By Procedural Volumes: –
Diagnostic Procedures
Therapeutic Procedures
Other
By Application: –
Oncology
Cardiology
Neurology
Thyroid
Lymphoma
Endocrinology
Other
By End User: –
Diagnostic Centers
Hospitals
Research Centers
Other
By Regional & Country Analysis
North America
U.S.
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Nuclear Medicine Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Nuclear Medicine Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Nuclear Medicine Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Nuclear Medicine Market Overview: Quantitative Analysis
4. Chapter – Global Nuclear Medicine Market Analysis: By Type
5. Chapter – Global Nuclear Medicine Market Analysis: By Procedural Volumes
6. Chapter – Global Nuclear Medicine Market Analysis: By Application
7. Chapter – Global Nuclear Medicine Market Analysis: By End User
8. Chapter – Global Nuclear Medicine Market Analysis: By Manufacturer
……………
10. Chapter – Company Profiles
10.1. Bracco Imaging S.P.A.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product portfolio
10.1.4. Nuclear Medicine Market Revenue (USD Million) and Market Share (%), 2014 – 2018
10.1.5. Nuclear Medicine Sales Market Share (%), 2014 – 2018
10.1.6. Business strategy
10.1.7. Recent developments
10.2. Cambridge Isotope Laboratories, Inc.
10.3. Cardinal Health, Inc.
10.4. Covidien, Plc
10.5. Eczacibasi-Monrol
10.6. Fujifilm Holdings Corporation
10.7. GE Healthcare (Subsidiary of General Electric Company)
10.8. IBA Group
10.9. Isotec
10.10. Ntp Radioisotopes (Pty), Ltd.
10.11. Siemens Healthcare (Subsidiary of Siemens AG)
10.12. Taiyo Nippon Sanso Corporation
10.13. Urenco Limited
10.14. Rotem Industries, Ltd., Inc.
10.15. Others
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz
Website: https://brandessenceresearch.biz
Related Report:
Medical Devices Industry Reports 2019
